Published in West J Med on April 01, 1982
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. A study of technical and metabolic features. Gastroenterology (1973) 1.87
The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally. J Clin Invest (1975) 1.38
Essential fatty acid deficiency in total parenteral nutrition: time course of development and suggestions for therapy. Surgery (1978) 1.21
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood (1976) 1.11
Essential fatty acid deficiency in surgical patients. Ann Surg (1977) 1.05
Fat overload with a 10% soybean oil emulsion. Arch Surg (1976) 1.04
Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc Natl Acad Sci U S A (1976) 1.03
Pulmonary vascular effects of fat emulsion infusion in unanesthetized sheep. Prevention by indomethacin. J Clin Invest (1978) 1.01
Fat emulsions for complete intravenous nutrition. Postgrad Med J (1967) 0.96
Total parenteral nutrition. Surgery (1978) 0.96
Postmortem findings in three patients treated with intravenous fat emulsions. Arch Surg (1979) 0.87
An evaluation of methods to monitor infants receiving intravenous lipids. J Pediatr (1979) 0.83
Coagulation studies after administration of a fat emulsion, intralipid. Thromb Diath Haemorrh (1967) 0.83
Alteration of the structure and function of guinea pig peritoneal macrophages by a soybean oil emulsion. Am J Pathol (1979) 0.79
Hematologic abnormalities associated with intravenous lipid therapy. A case report. Am J Gastroenterol (1980) 0.79
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med (1989) 2.61
Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest (1988) 2.53
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood (1996) 2.30
Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med (1985) 2.30
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood (1990) 2.09
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood (1985) 1.81
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood (1995) 1.79
Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. J Clin Oncol (1996) 1.64
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood (1991) 1.64
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood (1991) 1.61
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial. Br J Haematol (1989) 1.57
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood (1994) 1.57
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation (1973) 1.48
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant (1995) 1.47
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med (1983) 1.44
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med (1986) 1.41
[Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem]. Schweiz Med Wochenschr (1974) 1.41
Aplastic anaemia treated by marrow transplantation. Lancet (1972) 1.39
Marrow transplantation for acute myeloid leukemia. Cancer Invest (1998) 1.38
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 1.36
Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters. J Clin Invest (1981) 1.34
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol (1989) 1.33
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. J Clin Oncol (1993) 1.32
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood (1996) 1.26
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. Blood (1996) 1.25
Marrow harvesting from normal donors. Blood (1984) 1.25
Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison. Ann Intern Med (1984) 1.24
Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins. N Engl J Med (1974) 1.22
Growth and development following marrow transplantation for leukemia. Blood (1986) 1.20
Bacterial triterpenoids. Microbiol Rev (1984) 1.19
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1972) 1.17
Carotenoids in yellow-pigmented enterococci. J Bacteriol (1971) 1.14
Sudden and unexpected death in horses and ponies: an analysis of 200 cases. Equine Vet J (1988) 1.12
Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med (1978) 1.12
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood (1976) 1.11
Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation (1983) 1.10
Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med (1980) 1.09
Triterpenoid carotenoids and related lipids. The triterpenoid carotenes of Streptococcus faecium UNH 564P. Biochem J (1974) 1.09
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood (1993) 1.08
Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood (1979) 1.08
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. Blood (1997) 1.08
Feline brain abscesses due to Cladosporium trichoides. Sabouraudia (1977) 1.08
Specialized gastrointestinal units for the management of upper gastrointestinal haemorrhage. Postgrad Med J (1990) 1.08
Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood (1974) 1.06
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood (1993) 1.05
Opportunistic infection and interstitial pneumonia following marrow transplantation for aplastic anemia and hematologic malignancy. Transplant Proc (1976) 1.05
Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol (1976) 1.05
Bone marrow transplantation in patients aged 45 years and older. Blood (1986) 1.04
ABO-incompatible marrow transplants. Transplantation (1982) 1.04
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet (1982) 1.03
Candida endophthalmitis. Med J Aust (1975) 1.02
Oral manifestations of chronic graft-v-host disease. Arch Intern Med (1984) 1.02
ABO-incompatible marrow transplants. Transplantation (1978) 1.02
Unrelated donor marrow transplantation in children. Blood (1995) 1.01
Treatment of bone-marrow failure by isogeneic marrow infusion. N Engl J Med (1966) 1.01
Long-term outcome of gold eyelid weights in patients with facial nerve palsy. Otol Neurotol (2001) 1.01
Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. Am J Med (1985) 1.00
Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys (1982) 1.00
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med (1989) 1.00
Triterpenoid carotenoids and related lipids. Triterpenoid carotenoid aldehydes from Streptococcus faecium UNH 564P. Biochem J (1976) 0.99
Triterpenoid carotenoids and related lipids. Triterpenoid monohydroxy- and monoglucosyloxy-carotenoids from Streptococcus faecium UNH 564P. Biochem J (1974) 0.99
The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med (1982) 0.99
Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med (1978) 0.98
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol (1993) 0.98
Marrow transplantation for aplastic anemia. Semin Hematol (1984) 0.98
Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med (1980) 0.98
Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairs. Blood (1971) 0.98
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant (1996) 0.97
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood (1990) 0.97
One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle. Transplant Proc (1978) 0.97
The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood (1986) 0.96
Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors. Blood (1976) 0.95
Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys (1984) 0.95
Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood (1991) 0.94
Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol (1987) 0.94
Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. J Infect Dis (1983) 0.94